359 related articles for article (PubMed ID: 33746755)
21. Elucidation of the molecular mechanism of Sanguisorba Officinalis L. against leukopenia based on network pharmacology.
Wang L; Li H; Shen X; Zeng J; Yue L; Lin J; Yang J; Zou W; Li Y; Qin D; Wu A; Wu J
Biomed Pharmacother; 2020 Dec; 132():110934. PubMed ID: 33254437
[TBL] [Abstract][Full Text] [Related]
22.
Li H; Lin J; Yang F; Deng J; Lai J; Zeng J; Zou W; Jiang N; Huang Q; Li H; Liu J; Li M; Zhong Z; Wu J
Front Pharmacol; 2022; 13():1054803. PubMed ID: 36506573
[No Abstract] [Full Text] [Related]
23. Systems Pharmacology-Based Identification of Mechanisms of Action of Bolbostemma paniculatum for the Treatment of Hepatocellular Carcinoma.
Wang LL; Liao C; Li XQ; Dai R; Ren QW; Shi HL; Wang XP; Feng XS; Chao X
Med Sci Monit; 2021 Jan; 27():e927624. PubMed ID: 33436534
[TBL] [Abstract][Full Text] [Related]
24. Network Pharmacology Analysis and Experiments Validation of the Inhibitory Effect of JianPi Fu Recipe on Colorectal Cancer LoVo Cells Metastasis and Growth.
Lu X; Wu X; Jing L; Tao L; Zhang Y; Huang R; Zhang G; Ren J
Evid Based Complement Alternat Med; 2020; 2020():4517483. PubMed ID: 32774415
[TBL] [Abstract][Full Text] [Related]
25. The anti-hepatocellular carcinoma effect of Aidi injection was related to the synergistic action of cantharidin, formononetin, and isofraxidin through BIRC5, FEN1, and EGFR.
Lu S; Huang J; Zhang J; Wu C; Huang Z; Tao X; You L; Stalin A; Chen M; Li J; Tan Y; Wu Z; Geng L; Li Z; Fan Q; Liu P; Lin Y; Zhao C; Wu J
J Ethnopharmacol; 2024 Jan; 319(Pt 2):117209. PubMed ID: 37757991
[TBL] [Abstract][Full Text] [Related]
26. Study on the regulatory mechanism and experimental verification of icariin for the treatment of ovarian cancer based on network pharmacology.
Wang S; Gao J; Li Q; Ming W; Fu Y; Song L; Qin J
J Ethnopharmacol; 2020 Nov; 262():113189. PubMed ID: 32736044
[TBL] [Abstract][Full Text] [Related]
27. The Yunnan national medicine Maytenus compound inhibits the proliferation of hepatocellular carcinoma (HCC) by suppressing the activation of the EGFR-PI3K-AKT signaling pathway.
Zhao WT; Han LX; Liu L; Zeng BZ; Zhang Y; Zhao LF; Hu HY; Xia JW; Li YZ; Xiang XD; Lin XL; Lu D; Li GF
J Cancer; 2021; 12(11):3325-3334. PubMed ID: 33976742
[No Abstract] [Full Text] [Related]
28. Network Pharmacology-Based Study on the Molecular Biological Mechanism of Action for Compound Kushen Injection in Anti-Cancer Effect.
He R; Ou S; Chen S; Ding S
Med Sci Monit; 2020 Jan; 26():e918520. PubMed ID: 31892693
[TBL] [Abstract][Full Text] [Related]
29. Systems Pharmacology-Based Strategy to Investigate the Mechanism of Ruangan Lidan Decoction for Treatment of Hepatocellular Carcinoma.
Chen C; Liang T; Wu Q; Zhou Z; Zhang M; Feng D; Tao J; Si T; Cai M
Comput Math Methods Med; 2022; 2022():2940654. PubMed ID: 36578460
[TBL] [Abstract][Full Text] [Related]
30. Metabolomics and integrated network pharmacology analysis reveal SNKAF decoction suppresses cell proliferation and induced cell apoptisis in hepatocellular carcinoma via PI3K/Akt/P53/FoxO signaling axis.
Guo W; Yao X; Lan S; Zhang C; Li H; Chen Z; Yu L; Liu G; Lin Y; Liu S; Chen H
Chin Med; 2022 Jun; 17(1):76. PubMed ID: 35725485
[TBL] [Abstract][Full Text] [Related]
31. Network Pharmacology-Based Study on the Mechanism of
Wang Q; Liang Y; Peng C; Jiang P
Evid Based Complement Alternat Med; 2020; 2020():8897918. PubMed ID: 33163086
[TBL] [Abstract][Full Text] [Related]
32. Integrated Network Pharmacology and Experimental Verification to Explore the Molecular Mechanism of Hedysarum Multijugum Maxim-Curcumae Rhizoma Herb Pair for Treating Non-Small Cell Lung Cancer.
Hu S; Ge M; Zhang S; Jiang M; Hu K; Gao L
Front Oncol; 2022; 12():854596. PubMed ID: 35433443
[TBL] [Abstract][Full Text] [Related]
33. Integrated System Pharmacology Approaches to Elucidate Multi-Target Mechanism of
Khalid HR; Aamir M; Tabassum S; Alghamdi YS; Alzamami A; Ashfaq UA
Molecules; 2022 Sep; 27(19):. PubMed ID: 36234758
[TBL] [Abstract][Full Text] [Related]
34. BEZ235 increases sorafenib inhibition of hepatocellular carcinoma cells by suppressing the PI3K/AKT/mTOR pathway.
Li A; Zhang R; Zhang Y; Liu X; Wang R; Liu J; Liu X; Xie Y; Cao W; Xu R; Ma Y; Cai W; Wu B; Cai S; Tang X
Am J Transl Res; 2019; 11(9):5573-5585. PubMed ID: 31632530
[TBL] [Abstract][Full Text] [Related]
35.
Zhang W; Ou L; Peng C; Sang S; Feng Z; Zou Y; Yuan Y; Li H; Zhang G; Yao M
Heliyon; 2023 Jun; 9(6):e16798. PubMed ID: 37484409
[TBL] [Abstract][Full Text] [Related]
36. A combined network pharmacology and molecular biology approach to investigate the active ingredients and potential mechanisms of mulberry (Morus alba L.) leaf on obesity.
Li R; Wang C; Chen Y; Li N; Wang Q; Zhang M; He C; Chen H
Phytomedicine; 2021 Nov; 92():153714. PubMed ID: 34508977
[TBL] [Abstract][Full Text] [Related]
37. Echinacea purpurea suppresses the cell survival and metastasis of hepatocellular carcinoma through regulating the PI3K/Akt pathway.
Xu W; Hu B; Cheng Y; Guo Y; Yao W; Qian H
Int J Biochem Cell Biol; 2022 Jan; 142():106115. PubMed ID: 34743003
[TBL] [Abstract][Full Text] [Related]
38. Network pharmacology-based strategy to investigate pharmacological mechanisms of Tinospora sinensis for treatment of Alzheimer's disease.
Zhou F; He K; Guan Y; Yang X; Chen Y; Sun M; Qiu X; Yan F; Huang H; Yao L; Liu B; Huang L
J Ethnopharmacol; 2020 Sep; 259():112940. PubMed ID: 32389853
[TBL] [Abstract][Full Text] [Related]
39. Exploring the potential targets of Sanshimao formula for hepatocellular carcinoma treatment by a method of network pharmacology combined with molecular biology.
Yu Q; Chen Z; Liu M; Meng Y; Li X; Li B; Du J
J Ethnopharmacol; 2022 Oct; 297():115531. PubMed ID: 35840058
[TBL] [Abstract][Full Text] [Related]
40. Integrated network pharmacology and experimental verification to investigate the mechanisms of YYFZBJS against colorectal cancer
Li J; Zhou F; Shang L; Liu N; Liu Y; Zhang M; Wang S; Yang S
Front Oncol; 2022; 12():961653. PubMed ID: 36457504
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
